Importantly, analysis of genetic alterations from different cancer genome sequencing studies using cBioportal [20,21] revealed that KEAP1/NFE2L2 mutations are highly frequent in NSCLC, endometrial cancer, ovarian cancer, nerve sheath tumor and various forms of squamous cell carcinoma including cervical cancer. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.